EU hits France's Sanofi with flu vaccine antitrust probe
AI Summary
The European Commission has initiated an antitrust investigation against French pharmaceutical company Sanofi over suspected violations of competition rules related to the promotion of a flu vaccine. The probe aims to assess whether Sanofi engaged in anti-competitive practices.
The European Commission announced Friday that it was opening an antitrust probe into French pharmaceutical group Sanofi on suspicion it breached the bloc's competition rules in promoting a flu vaccine.